VEGFA and neoplasm: Because translational biomarkers such as angiopoietin‐2, VEGF‐A, and vascular cell adhesion molecule‐1, tumor mutational burden, and other gene signatures were not assessed,26 further studies using laboratory and histological samples are warranted to guide more information for treatment.